Visualising and quantifying angiogenesis in metastatic colorectal cancer: A comparison of methods and their predictive value for chemotherapy response

Cellular Oncology

Volumn 36, Issue 4, 2013, Pages 341-350

  Hansen, Torben Frøstrup ^a,c,d   Nielsen, Boye Schnack ^b   Jakobsen, Anders ^a,c,d   Sørensen, Flemming Brandt ^a,c,d  

^a LILLEBAELT HOSPITAL   (Denmark)

^b BIONEER A S   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Danish Colorectal Cancer Group South   (Denmark)

Author keywords

Angiogenesis; Chemotherapy; Colorectal neoplasms; MicroRNA; Microvessel density; Predictive biomarkers

Indexed keywords

CAPECITABINE; CAPECITABINE PLUS OXALIPLATIN; CD34 ANTIGEN; MICRORNA 126; OXALIPLATIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER CHEMOTHERAPY; CAPILLARY DENSITY; CHEMORADIOTHERAPY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TREATMENT RESPONSE;

EID: 84881659562     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-013-0139-3     Document Type: Article

References (39)

1. D. Hanahan, R.A. Weinberg, The hallmarks of cancer. Cell 100, 57-70 (2000)
2. R.T. Tong, Y. Boucher, S.V. Kozin, F. Winkler, D.J. Hicklin, R.K. Jain, Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res. 64, 3731-3736 (2004)
3. H. Wildiers, G. Guetens, B.G. De, E. Verbeken, B. Landuyt, B. Landuyt, E.A. Bruijn, A.T. van Oosterom, Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11. Br. J. Cancer 88, 1979-1986 (2003)
4. C.G. Willett, D.G. Duda, E. di Tomaso, Y. Boucher, B.G. Czito, Z. Vujaskovic, G. Vlahovic, J. Bendell, K.S. Cohen, H.I. Hurwitz, Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. Nat. Clin. Pract. Oncol. 4, 316-321 (2007)
5. K. Akagi, Y. Ikeda, Y. Sumiyoshi, Y. Kimura, J. Kinoshita, M. Miyazaki, T. Abe, Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development. Surgery 131, S109-S113 (2002)
6. G.G. Des, B. Uzzan, P. Nicolas, M. Cucherat, J.F. Morere, R. Benamouzig, J.L. Breau, G.Y. Perret, Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br. J. Cancer 94, 1823-1832 (2006)
7. P. Bossi, G. Viale, A.K. Lee, R. Alfano, G. Coggi, S. Bosari, Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res. 55, 5049-5053 (1995)
8. Y. Takebayashi, S. Aklyama, K. Yamada, S. Akiba, T. Aikou, Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer 78, 226-231 (1996)
9. L. Hlatky, P. Hahnfeldt, J. Folkman, Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J. Natl. Cancer Inst. 94, 883-893 (2002)
10. E. Fonsatti, V.L. Del, M. Altomonte, L. Sigalotti, M.R. Nicotra, S. Coral, P.G. Natali, M. Maio, Endoglin: an accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. J. Cell. Physiol. 188, 1-7 (2001)
11. D.W. Miller, W. Graulich, B. Karges, S. Stahl, M. Ernst, A. Ramaswamy, H.H. Sedlacek, R. Muller, J. Adamkiewicz, Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells. Int. J. Cancer 81, 568-572 (1999)
12. R. Minhajat, D. Mori, F. Yamasaki, Y. Sugita, T. Satoh, O. Tokunaga, Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers. Virchows Arch. 448, 127-134 (2006)
13. D. Royston, D.G. Jackson, Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J. Pathol. 217, 608-619 (2009)
14. A. Esquela-Kerscher, F.J. Slack, Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269 (2006)
15. W. Filipowicz, S.N. Bhattacharyya, N. Sonenberg, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9, 102-114 (2008)
16. J.E. Fish, D. Srivastava, MicroRNAs: opening a new vein in angiogenesis research. Sci. Signal. 2, pe1 (2009)
17. A. Kuehbacher, C. Urbich, A.M. Zeiher, S. Dimmeler, Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ. Res. 101, 59-68 (2007)
18. S. Jorgensen, A. Baker, S. Moller, B.S. Nielsen, Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 52, 375-381 (2010)
19. J.E. Fish, M.M. Santoro, S.U. Morton, S. Yu, R.F. Yeh, J.D. Wythe, K.N. Ivey, B.G. Bruneau, D.Y. Stainier, D. Srivastava, miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 15(272-284) (2008)
20. S. Wang, A.B. Aurora, B.A. Johnson, X. Qi, J. McAnally, J.A. Hill, J.A. Richardson, R. Bassel-Duby, E.N. Olson, The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15, 261-271 (2008)
21. E. Wienholds, W.P. Kloosterman, E. Miska, E. Alvarez-Saavedra, E. Berezikov, E. de Bruijn, H.R. Horvitz, S. Kauppinen, R.H. Plasterk, MicroRNA expression in zebrafish embryonic development. Science 309, 310-311 (2005)
22. B.S. Nielsen, S. Jorgensen, J.U. Fog, R. Sokilde, I.J. Christensen, U. Hansen, N. Brunner, A. Baker, S. Moller, H.J. Nielsen, High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin. Exp. Metastasis 28, 27-38 (2011)
23. T.F. Hansen, F.B. Soerensen, J. Lindebjerg, A. Jakobsen, The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer. BMC Cancer 12, 83 (2012)
24. S. Hansen, D.A. Grabau, C. Rose, M. Bak, F.B. Sorensen, Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab. Invest. 78, 1563-1573 (1998)
25. R. Rajaganeshan, R. Prasad, P.J. Guillou, C.R. Chalmers, N. Scott, R. Sarkar, G. Poston, D.G. Jayne, The influence of invasive growth pattern and microvessel density on prognosis in colorectal cancer and colorectal liver metastases. Br. J. Cancer 96, 1112-1117 (2007)
26. A.A. Romani, A.F. Borghetti, R.P. Del, M. Sianesi, P. Soliani, The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count. J. Surg. Oncol. 93, 446-455 (2006)
27. T.F. Hansen, F.B. Sorensen, K.L. Spindler, D.A. Olsen, R.F. Andersen, J. Lindebjerg, I Brandslund, A Jakobsen, Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer. Virchows Arch. 456, 251-260 (2010)
28. H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth, W. Heim, J. Berlin, A. Baron, S. Griffing, E. Holmgren, Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 350, 2335-2342 (2004)
29. C.J. Allegra, G. Yothers, M.J. O'Connell, S. Sharif, N.J. Petrelli, L.H. Colangelo, J.N. Atkins, T.E. Seay, L. Fehrenbacher, R.M. Goldberg, Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08. J. Clin. Oncol. 29, 11-16 (2011)
30. S. Nicoli, C. Standley, P. Walker, A. Hurlstone, K.E. Fogarty, N.D. Lawson, MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 464, 1196-2000 (2010)
31. T.F. Hansen, C.L. Andersen, B.S. Nielsen, K.L. Spindler, F.B. Sorensen, J. Lindebjerg, I. Brandslund, A. Jakobsen, Elevated microRNA-126 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in colorectal cancer. Oncol Lett 2, 1101-1106 (2011)
32. K.J. Png, N. Halberg, M. Yoshida, S.F. Tavazoie, A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481, 190-194 (2011)
33. R.K. Jain, Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58-62 (2005)
34. R.K. Jain, Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat. Med. 7, 987-989 (2001)
35. V. Kulda, M. Pesta, O. Topolcan, V. Liska, V. Treska, A. Sutnar, K. Rupert, M. Ludvikova, V. Babuska, L. Holubec Jr., Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet. Cytogenet. 200, 154-160 (2010)
36. M.M. Vickers, J. Bar, I. Gorn-Hondermann, N. Yarom, M. Daneshmand, J.E. Hanson, C.L. Addison, T.R. Asmis, D.J. Jonker, J. Maroun, Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease. Clin. Exp. Metastasis 29, 123-132 (2011)
37. A.E. Lindenmayer, M. Miettinen, Immunophenotypic features of uterine stromal cells. CD34 expression in endocervical stroma. Virchows Arch. 426, 457-460 (1995)
38. M. Van de Rijn, R.V. Rouse, CD34. Appl Immunohistochem 2, 71-80 (1994)
39. Y. Xi, G. Nakajima, E. Gavin, C.G. Morris, K. Kudo, K. Hayashi, J. Ju, Systematic analysis of microRNA axpression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 13, 1668-1674 (2007)